DRKS00025813已完成不适用
Marker of humoral and cellular immunity six to eight months after completing immunization against COVID-19 in residents of long-term care facilities for the elderly
Institut für Medizinische Virologie, Universitätsklinikum Frankfurt0 个研究点目标入组 426 人开始时间: 2021年8月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 426
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 75 Years 至 one（—）
- 性别
- All
入选标准
- •Complete vaccination against COVID-19 6 to 8 months at the time of inclusion in the study. No known prior infection with SARS-CoV-2. Group 1: Age 75 years or older. Resident of long-term care facility for the elderly.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Detailed analysis of the immune responses after vaccination against Japanese Encephalitis in the elderly.EUCTR2010-020450-33-ATInstitute of Specific Prophylaxis and Tropical Medicine60
进行中（未招募）
1 期
Characterization of humoral and cellular immunity for tick-borne encephalitis (TBE) vaccination in allogeneic blood and marrow graft recipients: a pilot studyEUCTR2011-002928-41-ATMed. Uni. Wien, Klinik für Innere I52
进行中（未招募）
不适用
Characterisation of humoral and cellular immunity of low- and high-responder after TBE vaccinatioEUCTR2008-005800-24-ATMedizinische Universität Wien, Institut für Spezifische Prophylaxe und Tropenmedizin84
招募中
不适用
Detection of markers for immune pathophysiology and analysis of their prognostic value in patients with chronic thrombocytopenia without an increase in the number of bone marrow megakaryocytes: a prospective observation study.Pancytopenia, thrombocytopeniaJPRN-UMIN000002729Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science.50
已完成
不适用
Investigation of the humoral and cellular immunity against SARS-CoV2 in patients after kidney transplantation in pandemic timesU07.1COVID-19, virus identifiedDRKS00024171niversitätsklinikum Köln46